The nuclear factor-κ B inhibitor SN50 enhances the efficacy of B-cell maturation antigen-targeted chimeric antigen receptor T-cell therapy
Not available.
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-01-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/11912 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832590371597582336 |
|---|---|
| author | Jinlan Long Shufeng Xie Wenjie Zhang Weiyu Dou Yixin Wang Ruiheng Wang Han Liu Zhenshu Xu |
| author_facet | Jinlan Long Shufeng Xie Wenjie Zhang Weiyu Dou Yixin Wang Ruiheng Wang Han Liu Zhenshu Xu |
| author_sort | Jinlan Long |
| collection | DOAJ |
| description |
Not available.
|
| format | Article |
| id | doaj-art-061f5ead67aa4f4da2cb913f04824a72 |
| institution | Kabale University |
| issn | 0390-6078 1592-8721 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Ferrata Storti Foundation |
| record_format | Article |
| series | Haematologica |
| spelling | doaj-art-061f5ead67aa4f4da2cb913f04824a722025-01-23T19:44:16ZengFerrata Storti FoundationHaematologica0390-60781592-87212025-01-01999110.3324/haematol.2024.286689The nuclear factor-κ B inhibitor SN50 enhances the efficacy of B-cell maturation antigen-targeted chimeric antigen receptor T-cell therapyJinlan Long0Shufeng Xie1Wenjie Zhang2Weiyu Dou3Yixin Wang4Ruiheng Wang5Han Liu6Zhenshu Xu7Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital, FuzhouShanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine and School of Life Sciences and Biotechnology, ShanghaiFujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital, FuzhouEmergency Department, Chinese PLA Southern Theater Command General Hospital, GuangzhouShanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine and School of Life Sciences and Biotechnology, ShanghaiShanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine and School of Life Sciences and Biotechnology, ShanghaiShanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine and School of Life Sciences and Biotechnology, ShanghaiFujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital, Fuzhou Not available. https://haematologica.org/article/view/11912 |
| spellingShingle | Jinlan Long Shufeng Xie Wenjie Zhang Weiyu Dou Yixin Wang Ruiheng Wang Han Liu Zhenshu Xu The nuclear factor-κ B inhibitor SN50 enhances the efficacy of B-cell maturation antigen-targeted chimeric antigen receptor T-cell therapy Haematologica |
| title | The nuclear factor-κ B inhibitor SN50 enhances the efficacy of B-cell maturation antigen-targeted chimeric antigen receptor T-cell therapy |
| title_full | The nuclear factor-κ B inhibitor SN50 enhances the efficacy of B-cell maturation antigen-targeted chimeric antigen receptor T-cell therapy |
| title_fullStr | The nuclear factor-κ B inhibitor SN50 enhances the efficacy of B-cell maturation antigen-targeted chimeric antigen receptor T-cell therapy |
| title_full_unstemmed | The nuclear factor-κ B inhibitor SN50 enhances the efficacy of B-cell maturation antigen-targeted chimeric antigen receptor T-cell therapy |
| title_short | The nuclear factor-κ B inhibitor SN50 enhances the efficacy of B-cell maturation antigen-targeted chimeric antigen receptor T-cell therapy |
| title_sort | nuclear factor κ b inhibitor sn50 enhances the efficacy of b cell maturation antigen targeted chimeric antigen receptor t cell therapy |
| url | https://haematologica.org/article/view/11912 |
| work_keys_str_mv | AT jinlanlong thenuclearfactorkbinhibitorsn50enhancestheefficacyofbcellmaturationantigentargetedchimericantigenreceptortcelltherapy AT shufengxie thenuclearfactorkbinhibitorsn50enhancestheefficacyofbcellmaturationantigentargetedchimericantigenreceptortcelltherapy AT wenjiezhang thenuclearfactorkbinhibitorsn50enhancestheefficacyofbcellmaturationantigentargetedchimericantigenreceptortcelltherapy AT weiyudou thenuclearfactorkbinhibitorsn50enhancestheefficacyofbcellmaturationantigentargetedchimericantigenreceptortcelltherapy AT yixinwang thenuclearfactorkbinhibitorsn50enhancestheefficacyofbcellmaturationantigentargetedchimericantigenreceptortcelltherapy AT ruihengwang thenuclearfactorkbinhibitorsn50enhancestheefficacyofbcellmaturationantigentargetedchimericantigenreceptortcelltherapy AT hanliu thenuclearfactorkbinhibitorsn50enhancestheefficacyofbcellmaturationantigentargetedchimericantigenreceptortcelltherapy AT zhenshuxu thenuclearfactorkbinhibitorsn50enhancestheefficacyofbcellmaturationantigentargetedchimericantigenreceptortcelltherapy AT jinlanlong nuclearfactorkbinhibitorsn50enhancestheefficacyofbcellmaturationantigentargetedchimericantigenreceptortcelltherapy AT shufengxie nuclearfactorkbinhibitorsn50enhancestheefficacyofbcellmaturationantigentargetedchimericantigenreceptortcelltherapy AT wenjiezhang nuclearfactorkbinhibitorsn50enhancestheefficacyofbcellmaturationantigentargetedchimericantigenreceptortcelltherapy AT weiyudou nuclearfactorkbinhibitorsn50enhancestheefficacyofbcellmaturationantigentargetedchimericantigenreceptortcelltherapy AT yixinwang nuclearfactorkbinhibitorsn50enhancestheefficacyofbcellmaturationantigentargetedchimericantigenreceptortcelltherapy AT ruihengwang nuclearfactorkbinhibitorsn50enhancestheefficacyofbcellmaturationantigentargetedchimericantigenreceptortcelltherapy AT hanliu nuclearfactorkbinhibitorsn50enhancestheefficacyofbcellmaturationantigentargetedchimericantigenreceptortcelltherapy AT zhenshuxu nuclearfactorkbinhibitorsn50enhancestheefficacyofbcellmaturationantigentargetedchimericantigenreceptortcelltherapy |